Fetching the paper…
Reading the bibliography…
In late December 2019, a novel strand of Coronavirus (SARS-CoV-2) causing a severe, potentially fatal respiratory syndrome (COVID-19) was identified in Wuhan, Hubei Province, China and is causing outbreaks in multiple world countries, soon becoming a pandemic.
W. O. Kermack and A. G. McKendrick, “A contribution to the mathematical theory of epidemics”, Proc. Royal Soc. London , 115:700-721, 1927
1927
Earlier work this paper cites.
R. M. Anderson and R. M. May, Infectious diseases of humans . Oxford University Press, London, 1991
1991
Earlier work this paper cites.
O. Diekmann and J. A. P. Heesterbeek. Mathematical epidemiology of infectious diseases: model building, analysis and interpretation . Wiley, New York, 2000
2000
Earlier work this paper cites.
H. W. Hethcote, “The mathematics of infectious diseases”, SIAM Rev. , 42:599-653, 2000
2000
Earlier work this paper cites.
2003
Earlier work this paper cites.
A. B. Gumel et al,. “Modelling strategies for controlling SARS outbreaks”, Proc. R. Soc. B Biol. Sci. , 2004, doi:10.1098/rspb.2004.2800
2004
Earlier work this paper cites.
M. L. Ciofi degli Atti et al., “Mitigation measures for pandemic influenza in Italy: an individual based model considering different scenarios”, PLoS One , 3(3):e1790, 2008
2008
Earlier work this paper cites.
F. Brauer & C. Castillo-Chavez, Mathematical Models in Population Biology and Epidemiology , 2nd Edition. Springer Texts in Applied Mathematics, 2012
2012
Earlier work this paper cites.
D. Fisman, C. Rivers, E. Lofgren, and M. S. Majumder, “Estimation of MERS-Coronavirus reproductive number and case fatality rate for the spring 2014 Saudi Arabia outbreak: insights from publicly available data”, PLoS Curr. , 2014, 10.1371/currents.outbreaks.98d2f8f3382d84f390736cd5f5fe133c
2014
Earlier work this paper cites.
T. P. Velavan and C. G. Meyer, “The COVID-19 epidemic”, Trop. Med. Int. Heal. , 25(3):278-280, 2020, doi:10.1111/tmi.13383
2020
Earlier work this paper cites.
Z. Wu and J. M. McGoogan, “Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention”, JAMA , 2020, doi:10.1001/jama.2020.2648
2020
Earlier work this paper cites.
W.-J. Guan et al., “Clinical Characteristics of Coronavirus Disease 2019 in China”, N. Engl. J. Med. , 2020, doi:10.1056/NEJMoa2002032
2020
Earlier work this paper cites.
WHO. Coronavirus disease 2019 (COVID-19): Situation Report – 23. Covid-19 Situational Reports, 2020
2020
Earlier work this paper cites.
A. Remuzzi and G. Remuzzi, “COVID-19 and Italy: what next?”, The Lancet Health Policy , 2020, https://doi.org/10.1016/S0140-6736(20)30627-9
2020
Earlier work this paper cites.
A. Giuffrida and P. Beaumont, “Coronavirus: inquiry opens into hospitals at centre of Italy outbreak”, The Guardian , 26 February 2020
2020
Cited alongside, same era.
Ministero della Salute, http://www.salute.gov.it/imgs/C_17_pagineAree_5351_16_file.pdf
2020
Cited alongside, same era.
Italian Civil Protection, “Situazione Italia al 5 marzo”, http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioNotizieNuovoCoronavirus.jsp?lingua=italiano\&menu=notizie\&p=dalministero\&id=4157
2020
Cited alongside, same era.
F. Locatelli, “Consiglio superiore sanità, tamponi solo a sintomatici”, ANSA bulletin , 26 February 2020
2020
Cited alongside, same era.
“Chronology of main steps and legal acts taken by the Italian Government for the containment of the COVID-19 epidemiological emergency”, http://www.protezionecivile.gov.it/documents/20182/1227694/Summary+of+measures+taken+against+the+spread+of+C-19/c16459ad-4e52-4e90-90f3-c6a2b30c17eb
A. J. Kucharski et al., “Early dynamics of transmission and control of COVID-19: a mathematical modelling study”, The Lancet Global Health , 2020, https://doi.org/10.1016/S1473-3099(20)30144-4
2020
Closest in time.
L. Lan et al., “Positive RT-PCR test results in patients recovered from COVID-19”, JAMA , 2020, doi:10.1001/jama.2020.2783
2020
Closest in time.
Y. Bai et al., “Presumed asymptomatic carrier transmission of COVID-19”, JAMA , 2020, doi:10.1001/jama.2020.2565
2020
Closest in time.
V. M. Corman et al., “Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR”, Euro Surveill. , 2020, 10.2807/1560-7917.ES.2020.25.3.2000045
2020
Closest in time.
J. Gallagher, “Are coronavirus tests flawed?”, BBC NEWS , 13 February 2020
2020
Closest in time.
alphaXiv searches the wider corpus for related work and actual follow-ups.
alphaXiv is searching for related work…
2020
Cited alongside, same era.
Y. Wang, Y. Wang, Y. Chen, and Q. Quin, “Unique epidemiological and clinical features of the emerging 2019 Novel Coronavirus Pneumonia (COVID-19) implicate special control measures”, J Med Virol , 2020, 10.1002/jmv.25748
2020
Cited alongside, same era.
S. Zhao et al., “Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak”, Int. J. Infectious Diseases , 92:214-217, 2020
2020
Cited alongside, same era.
J. Read, J. R. Bridgen, D. A. T. Cummings, A. Ho, and C. P. Jewell, “Novel coronavirus 2019-ncov: early estimation of epidemiological parameters and epidemic predictions”, medRxiv, 2020, doi:10.1101/2020.01.23.20018549
2020
Cited alongside, same era.
L. Zou et al., “SARS-CoV-2 viral load in upper respiratory specimens of infected patients”, N. Engl. J. Med. , 2020, 10.1056/NEJMc2001737
2020
Cited alongside, same era.
Q. Lin et al., “A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action”, Int. J. Infectious Diseases , 93:211-216, 2020
2020
Cited alongside, same era.
C. Anastassopoulou, L. Russo, A. Tsakris and C. Siettos, “Data-based analysis, modelling and forecasting of the COVID-19 outbreak”, medRxiv preprint, https://doi.org/10.1101/2020.02.11.20022186
2020
Cited alongside, same era.
J. Wu et al., “Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China”, Nature Medicine , 2020, https://doi.org/10.1038/s41591-020-0822-7
2020
Cited alongside, same era.
Z. Li et al., “Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis”, J. Med. Virol. , 2020, doi:10.1002/jmv.25727
2020
Closest in time.
K. Roosa et al., “Short-term forecasts of the COVID-19 epidemic in Guangdong and Zhejiang, China: February 13-23, 2020”, J. Clin. Med. , 2020, doi:10.3390/jcm9020596
2020
Closest in time.
C. Wang et al., “Risk management of COVID-19 by universities in China”, J. Risk Financ. Manag. , 2020, doi:10.3390/jrfm13020036
2020
Closest in time.
Y. Ji, Z. Ma, M. P. Peppelenbosch and Q. Pan, “Potential association between COVID-19 mortality and health-care resource availability”, The Lancet Global Health , 2020, https://doi.org/10.1016/S2214-109X(20)30068-1
2020
Closest in time.
M. Wang et al., “Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro”, Cell Research , 2020, doi:10.1038/s41422-020-0282-0
2020
Closest in time.
Y.-C. Chang et al., “Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking”, Med. Pharmacol. , 2020
2020
Closest in time.
B. Diao et al., “Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)”, medRxiv, 2020, doi:10.1101/2020.02.18.20024364
2020
Closest in time.
W.-H. Chen, U. Strych, P. J. Hotez and M. E. Bottazzi, “The SARS-CoV-2 vaccine pipeline: an overview”, Curr Trop Med Rep , 2020
2020
Closest in time.